Correlation Between Polar Capital and International Biotechnology

Can any of the company-specific risk be diversified away by investing in both Polar Capital and International Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Polar Capital and International Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Polar Capital Technology and International Biotechnology Trust, you can compare the effects of market volatilities on Polar Capital and International Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Polar Capital with a short position of International Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Polar Capital and International Biotechnology.

Diversification Opportunities for Polar Capital and International Biotechnology

0.71

Correlation Coefficient

Polar Capital  International Biotechnology

Poor diversification

The 3 months correlation between Polar and International is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Polar Capital Technology and International Biotechnology Tr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on International Biotechnology and Polar Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Polar Capital Technology are associated (or correlated) with International Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of International Biotechnology has no effect on the direction of Polar Capital i.e., Polar Capital and International Biotechnology go up and down completely randomly.

Pair Corralation between Polar Capital and International Biotechnology

Assuming the 90 days trading horizon Polar Capital is expected to generate 2.53 times less return on investment than International Biotechnology. But when comparing it to its historical volatility, Polar Capital Technology is 1.18 times less risky than International Biotechnology. It trades about 0.04 of its potential returns per unit of risk. International Biotechnology Trust is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  67,092  in International Biotechnology Trust on September 23, 2024 and sell it today you would earn a total of  1,308  from holding International Biotechnology Trust or generate 1.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Polar Capital Technology  vs.  International Biotechnology Tr

Polar Capital Technology

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Polar Capital Technology are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Polar Capital exhibited solid returns over the last few months and may actually be approaching a breakup point.

International Biotechnology

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in International Biotechnology Trust are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, International Biotechnology is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Polar Capital and International Biotechnology

The main advantage of trading using opposite Polar Capital and International Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Polar Capital position performs unexpectedly, International Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Biotechnology will offset losses from the drop in International Biotechnology's long position.

The idea behind Polar Capital Technology and International Biotechnology Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.